Related Experiment Videos
Adverse outcomes associated with pediatric dental sedation: Claims data analysis, 2014-2019
Kawtar Zouaidi1, Colin C Hubbard2, Matthew R Cooke3
1Texas Center for Oral Healthcare Quality and Safety, School of Dentistry, UTHealth Houston, Houston, TX.
Journal of the American Dental Association (1939)
|June 13, 2026
Summary
One in 27 pediatric dental sedation visits results in an adverse outcome, particularly for older children and those with chronic conditions. Risk mitigation strategies are crucial for improving patient safety in dental sedation.
Area of Science:
- Pediatric Dentistry
- Dental Sedation Safety
- Health Services Research
Background:
- High-risk medications are frequently used in pediatric dentistry.
- Existing medication safety evidence primarily focuses on medical settings, with limited data from dental environments.
- This study assesses adverse outcomes linked to pediatric dental sedation.
Purpose of the Study:
- To evaluate the incidence and risk factors associated with adverse outcomes following dental sedation in children.
- To identify patient and setting characteristics that increase the likelihood of adverse events.
- To inform targeted safety improvements in pediatric dental sedation practices.
Main Methods:
- Analysis of MarketScan data for pediatric patients (under 18) undergoing dental sedation between 2014-2019.
- Composite outcomes included emergency visits or hospitalization within 7 days; attributable outcomes focused on sedation-related adverse events.
- Multivariable generalized estimating equations were used to model associations between patient/setting characteristics and outcomes.
Main Results:
- Four percent of all sedations were linked to a composite adverse outcome.
- Increased odds of composite outcomes were observed in older children (12-17 years), those with chronic conditions, Medicaid coverage, and prior medical visits.
- Sedation-related adverse outcomes occurred in 0.18% of cases, with higher likelihood in children with complex chronic conditions, Medicaid coverage, and in hospital/ambulatory surgery settings compared to outpatient clinics.
Conclusions:
- Approximately 1 in 27 pediatric dental sedation visits is associated with an adverse outcome.
- Targeted risk-mitigation strategies are essential for high-risk pediatric populations undergoing dental sedation.
- Enhancing safety necessitates comprehensive presedation assessments, vigilant monitoring, provider training, and adherence to clinical guidelines.
Related Concept Videos
Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Local Anesthetics: Adverse Effects
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Stages of General Anesthesia
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...